On August 9, 2001, President George W. Bush delivered an extraordinaryprime-time television address to the nation that was devotedexclusively to an arcane topic of basic biomedical research:human embryonic stem cells. After months of factfinding andrancorous debate, Bush announced that federal funding wouldindeed be provided for the study of these remarkable cells,though only for preexisting stocks. Although disappointing tothose who had hoped he would banish all such research, Bush'sdecision was at its core an endorsement of the promise of humanembryonic stem cells and their importance to the fledgling fieldof regenerative medicine.
From the Whitehead Institute for Biomedical Research, Cambridge, and Harvard Medical School, Boston.
This article has been cited by other articles:
Zon, R. T., Goss, E., Vogel, V. G., Chlebowski, R. T., Jatoi, I., Robson, M. E., Wollins, D. S., Garber, J. E., Brown, P., Kramer, B. S.
(2009). American Society of Clinical Oncology Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment. JCO
27: 986-993
[Abstract][Full Text]
Intemann, K. K., Inmaculada de Melo-Martin,
(2008). Regulating scientific research: should scientists be left alone?. FASEB J.
22: 654-658
[Abstract][Full Text]
Brodie, J. C., Humes, H. D.
(2005). Stem Cell Approaches for the Treatment of Renal Failure. Pharmacol. Rev.
57: 299-313
[Abstract][Full Text]
Thompson, I. M., Ankerst, D. P., Chi, C., Lucia, M. S., Goodman, P. J., Crowley, J. J., Parnes, H. L., Coltman, C. A. Jr
(2005). Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower. JAMA
294: 66-70
[Abstract][Full Text]